Minimal clinically important differences for measures of treatment efficacy in Stevens-Johnson syndrome and toxic epidermal necrolysis

Journal article

Open access

Peer reviewed

W.B. Kim, B. Worley, J. Holmes, E.J. Phillips and J. Beecker

Journal of the American Academy of Dermatology, Vol.79(6), pp.1150-1152

2018

Files and links (2)

pdf

Steven Johnson Syndrome.pdfDownload View

Author’s Version Open Access

url

Link to Published Version *Subscription may be requiredView

Keywords Stevens-Johnson syndrome and toxic epidermal necrolysis (SJS/TEN) minimal clinically important difference (MCID)

Title: Minimal clinically important differences for measures of treatment efficacy in Stevens-Johnson syndrome and toxic epidermal necrolysis
Authors/Creators: W.B. Kim (Author/Creator) - University of Ottawa
B. Worley (Author/Creator) - University of Ottawa
J. Holmes (Author/Creator) - Wake Forest University
E.J. Phillips (Author/Creator) - Vanderbilt University Medical Center
J. Beecker (Author/Creator) - University of Ottawa
Publication Details: Journal of the American Academy of Dermatology, Vol.79(6), pp.1150-1152
Publisher: Elsevier
Identifiers: 991005542056207891
Copyright: © 2018 by the American Academy of Dermatology, Inc.
Murdoch Affiliation: Institute for Immunology and Infectious Diseases
Language: English
Resource Type: Journal article

This output has contributed to the advancement of the following goals:

Source: InCites

104 File views/ downloads

51 Record Views

These are selected metrics from InCites Benchmarking & Analytics tool, related to this output

Collaboration types: Domestic collaboration; International collaboration
Citation topics: 1 Clinical & Life Sciences; 1.265 Dermatology - Skin Allergies; 1.265.1140 Drug Hypersensitivity
Web Of Science research areas: Dermatology
ESI research areas: Clinical Medicine